Pfizer-BioNTech COVID-19 Booster Dose Recommendations for Persons 16 through 17 Years of Age and Storage and Handling Guidance on Pfizer’s New Gray Cap - Shared screen with speaker view
Who can see your viewing activity?
If not discussed in this slide set, please speak on vaccinated individuals whom are "breakthrough" cases and when they can receive a "booster" dose. Thank you!
Here is the link to the FDA information that Andrea mentioned: https://www.fda.gov/media/154870/download
Hello, I wanted to make sure my email was on the list server, my email is: firstname.lastname@example.org
can we draw up all the doses in the gray cap at the same time and leave them at room temp ?
@Gordon Satoh, thank you for this comment. We are not discussing breakthrough cases in this presentation but we will send a follow up to your comment in our follow up email that we send out. For now, if a person has had COVID-19 breakthrough infection after receiving their primary series they can receive a booster dose 6 months after their primary series was completed and ensure vaccination is deferred until person has recovered from the acute illness and criteria have been met for them to discontinue isolation. (https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html). This information can be found in the clinical considerations: https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#vaccinating-exposure . We will send a follow up regarding this with all the resources to give further detail in our follow up email that will be sent. Thank you.
@Daniela--thank you and we will note this :)
Is there any way to get more diluent (we have misplaced some)?
@amber--this is a great question and based on CDC previous guidance doses have been able to be stored in a syringe for a period of time. HOWEVER, we do not have all the detail yet from CDC and will verify the specifics on this for you and be sure to share that as soon as we know.
May I get the slides NIBC1112@aol.com
Heidi and Andrea... my concern about pre-drawing doses of COVID-19 vaccine... vaccinators need to see the patient before they choose a 1" needle or a 1.5" needle... if they do not wait to see the patient, they will be tempted to use a 1" needle even when the patient is large and has a lot of subcutaneous tissue over the muscle...
Please send the website with the upcoming email
the supplies we have been getting from the OCHD have been with syringes that we cant change the needle on.
Is it also mentioned that one must be careful not to compress the deltoid muscle (raising the subcutaneous tissues) but just support the deltoid muscle?
Same to you ladies!
Angela Reed (she/hers)
Thanks, Ladies! Happy Holidays!